Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung

Journal of Thoracic Oncology

Volumn 5, Issue 7, 2010, Pages 964-969

  Yoo, Seol Bong ^a   Chung, Jin Haeng ^a   Lee, Hyun Ju ^a   Lee, Choon Taek ^a   Jheon, Sanghoon ^a   Sung, Sook Whan ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Adenocarcinoma; Carcinogenesis; Epidermal growth factor receptor (EGFR); Lung neoplasm; p53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; EGFR PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ATYPICAL ADENOMATOUS HYPERPLASIA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CONTROLLED STUDY; EXON; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PATHOGENESIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ADENOCARCINOMA; CANCER STAGING; DISEASE COURSE; ENZYME IMMUNOASSAY; GENETICS; LUNG ADENOMA; LUNG TUMOR; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PRECANCER; PROGNOSIS; TUMOR INVASION; VERY ELDERLY;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADENOMATOSIS, PULMONARY; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954426875     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181dd15c0     Document Type: Article

References (33)

1. Feinstein MB, Bach PB. Epidemiology of lung cancer. Chest Surg Clin N Am 2000;10:653-661.
2. Lantuejoul S, Salameire D, Salon C, et al. Pulmonary preneoplasia\ sequential molecular carcinogenetic events. Histopathology 2009;54: 43-54.
3. Soh J, Toyooka S, Ichihara S, et al. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung. J Thorac Oncol 2008;3:340-347. (Pubitemid 351489472)
4. Yoshida Y, Shibata T, Kokubu A, et al. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 2005;50:1-8. (Pubitemid 41297463)
5. Sakamoto H, Shimizu J, Horio Y, et al. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive ade-nocarcinomas. J Pathol 2007;212:287-294. (Pubitemid 47010062)
6. Sakuma Y, Matsukuma S, Yoshihara M, et al. Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung. Mod Pathol 2007;20:967-973. (Pubitemid 47267825)
7. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802. (Pubitemid 26392633)
8. Chung JH, Choe G, Jheon S, et al. EGFR mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity could differentiate multicentric origin from intrapulmonary spread. J Thorac Oncol 2009;4:1490-1495.
9. Myung JK, Choe G, Chung DH, et al. A simple inflation method for frozen section diagnosis of minute precancerous lesions of the lung. Lung Cancer 2008;59:198-202. (Pubitemid 351173411)
10. Sekido Y, Fong KM, Minna JD. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1998;1378: F21-F59. (Pubitemid 28381125)
11. Fong KM, Sekido Y, Minna JD. Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 1999;118:1136-1152.
12. Breuer RH, Postmus PE, Smit EF. Molecular pathology of non-small-cell lung cancer. Respiration 2005;72:313-330. (Pubitemid 40981094)
13. Tokumo M, Toyooka S, Kiura K, et al. The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers. Clin Cancer Res 2005;11:1167-1173. (Pubitemid 40175767)
14. Kosaka T, Yatabe Y, Endoh H, et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-8923. (Pubitemid 39665498)
15. Harris CC. p53 tumor suppressor gene: from the basic research laboratory to the clinic\an abridged historical perspective. Carcinogenesis 1996;17:1187-1198.
16. Sekido Y, Fong KM, Minna JD. Molecular genetics of lung cancer. Annu Rev Med 2003;54:73-87. (Pubitemid 37386386)
17. Toyooka S, Tsuda T, Gazdar AF. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 2003;21:229-239. (Pubitemid 36292965)
18. Gazzeri S, Brambilla E, Caron de Fromentel C, et al. p53 genetic abnormalities and myc activation in human lung carcinoma. Int J Cancer 1994;58:24-32. (Pubitemid 24213965)
19. Hashimoto T, Tokuchi Y, Hayashi M, et al. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Cancer Res 1999;59:5572-5577. (Pubitemid 29526476)
20. Gao WM, Mady HH, Yu GY, et al. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types. Lung Cancer 2003;40:141-150
21. Travis WD, Brambilla E, Muller-Hermeling HK, et al. (Eds.), Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization classification of Tumours. Lyon: IARC Press, 2004.
22. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995;75: 2844-2852.
23. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304: 1497-1500. (Pubitemid 38720929)
24. Baek MJ, Kang H, Kim SE, et al. Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer 2001;85:1147-1152. (Pubitemid 33052313)
25. Kim HS, Woo DK, Bae SI, et al. Microsatellite instability in the adenoma-carcinoma sequence of the stomach. Lab Invest 2000;80:57-64.
26. Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer 2003;2:41. (Pubitemid 38751457)
27. Samowitz WS, Holden JA, Curtin K, et al. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 2001;158:1517-1524. (Pubitemid 32281315)
28. Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005;65:7568-7572. (Pubitemid 41297226)
29. Tang X, Varella-Garcia M, Xavier AC, et al. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas. Cancer Prev Res (Phila Pa) 2008;1:192-200.
30. Piyathilake CJ, Frost AR, Manne U, et al. Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers. Chest 2003;123:181-186. (Pubitemid 36131111)
31. Martin B, Verdebout JM, Mascaux C, et al. Expression of p53 in preneoplastic and early neoplastic bronchial lesions. Oncol Rep 2002;9: 223-229.
32. Kitaguchi S, Takeshima Y, Nishisaka T, et al. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung. Hiroshima J Med Sci 1998;47: 17-25. (Pubitemid 128515983)
33. Tomizawa Y, Kohno T, Fujita T, et al. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. Oncogene 1999;18:1007-1014. (Pubitemid 29086277)